Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Brufen Retard 800mg tablets
1001010J0BCAFAP
|
Brufen | Ibuprofen | Musculoskeletal and Joint Diseases | 540 |
|
Brufen 400mg tablets
1001010J0BCABAE
|
Brufen | Ibuprofen | Musculoskeletal and Joint Diseases | 96 |
|
Brufen 600mg effervescent granules sachets
1001010J0BCAEAN
|
Brufen | Ibuprofen | Musculoskeletal and Joint Diseases | 33 |
|
Brufen 100mg/5ml syrup
1001010J0BCADAC
|
Brufen | Ibuprofen | Musculoskeletal and Joint Diseases | 32 |
|
Brufen 600mg tablets
1001010J0BCACAF
|
Brufen | Ibuprofen | Musculoskeletal and Joint Diseases | 2 |
|
Brufen 200mg tablets
1001010J0BCAAAD
|
Brufen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.